Invictus MD Strategies Corp. (V:GENE)
Business Focus: N/A
Feb 14, 2023 09:21 pm ET
TSX Venture Exchange Stock Maintenance Bulletins
VANCOUVER, BC, Feb. 14, 2023 /CNW/ -
Jan 26, 2021 06:32 pm ET
Invictus Announces Share Issuance
VANCOUVER, BC, Jan. 26, 2021 /CNW/ - Invictus MD Strategies Corp. (NEX: GENE.H) (the "Company") announced today, further to the Company's news release of December 16, 2020, that the Company has completed the issuance of 1,121,248,467 Invictus common shares (the "Subscribed Shares"). The Subscribed Shares are equal to 90% of Invictus' issued share capital on completion of the transaction, resulting in existing shareholders retaining an aggregate 10% interest in the Company. The subscription proceeds will be used to repay existing secured creditors of the Company, to pay costs associated with
Dec 16, 2020 07:30 am ET
Invictus Announces Signing of a Purchase Agreement
VANCOUVER, BC, Dec. 16, 2020 /CNW/ - Invictus MD Strategies Corp. (NEX: GENE.H) (the "Company") announced today that it has entered into an agreement (the "Subscription Agreement") for the issuance of 1,121,248,467 Invictus common shares (the "Subscribed Shares"). The Subscribed Shares will be equal to 90% of Invictus' issued share capital on completion of the transaction. As a result, on completion of the transaction existing shareholders will retain an aggregate 10% interest in the Company. It is anticipated that the subscription proceeds will be used to repay existing secured creditors
Oct 19, 2020 12:29 pm ET
IIROC Trading Halt - GENE.WT
VANCOUVER, BC, Oct. 19, 2020 /CNW/ - The following issues have been halted by IIROC:
Jul 31, 2020 08:07 pm ET
Invictus Announces Signing of a Purchase Agreement
VANCOUVER, BC, July 31, 2020 /CNW/ - Invictus MD Strategies Corp. (NEX: GENE.H) (the "Company") announced that it has received both creditor and Court approval of the investment agreement for the sale of its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage"), to Acreage Developments Corp. (the "Investor"), a privately-owned company that is unrelated to the Company and its directors and officers.
Jun 22, 2020 07:00 am ET
Invictus Announces Signing of a Purchase Agreement
VANCOUVER, BC, June 22, 2020 /CNW/ - Invictus MD Strategies Corp. (NEX: GENE.H) (the "Company") announced today that it has entered into an investment agreement for the sale of its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage"). The purchaser is Acreage Developments Corp. (the "Investor"), a privately-owned company that is unrelated to the Company and its directors and officers.
May 20, 2020 02:24 pm ET
Invictus MD Strategies Corp. - Change of Management
VANCOUVER, May 20, 2020 /CNW/ - Invictus MD Strategies Corp. (NEX: GENE.H) (the "Company") announced that Ms. Harbir Toor has ceased to be the Company's Chief Financial Officer, effective immediately. The Company wishes to thank Ms. Toor for her service.
May 01, 2020 10:09 am ET
Invictus Announces Director Resignation
VANCOUVER, May 1, 2020 /CNW/ - Invictus MD Strategies Corp. (NEX: GENE.H) (the "Company") announced today the resignation of Mr. Marc Ripa from, and appointment of Ms. Brenda Dixon to, the Board of Directors of the Company. Ms. Dixon is currently a director of Acreage Pharms Ltd., a wholly owned subsidiary of the Company and holds a Master's degree in Public Administration and a Bachelor of Science in Biology. Ms. Dixon has worked nationally and internationally with diverse industry and regulatory agencies on Environmental Quality issues for many years. Ms. Dixon said "I'm most pleased to
Mar 24, 2020 04:34 pm ET
Invictus MD Strategies Corp. - Notice of Sale and Investment Solicitation Process
VANCOUVER, March 24, 2020 /CNW/ - INVICTUS MD STRATEGIES CORP. (NEX: GENE.H;) (the "Company") announced that the Company, Greener Pastures MD Ltd., Acreage Pharms Ltd. ("Acreage") and 2015059 Alberta Ltd. (collectively, the "Invictus Group") have received an order (the "Order") from the Supreme Court of British Columbia (the "Court") that approves the Invictus Group's proposed sale and investment solicitation process ("SISP") in respect of their businesses and assets in connection with the Invictus Group's ongoing Companies' Creditors Arrangement Act ("CCAA") proceedings.
Feb 27, 2020 08:11 am ET
Invictus Announces Resignations
VANCOUVER, Feb. 27, 2020 /CNW/ - INVICTUS MD STRATEGIES CORP. (NEX: GENE.H) (the "Company") announced today the resignations of Mr. Richard Lee from the Board of Directors of the Company and Ms. Kathy Love, Corporate Secretary of the Company, effective immediately. The Company wishes to thank Mr. Lee and Ms. Love for their service.
Feb 27, 2020 07:46 am ET
IIROC Trading Halt - GENE.H
VANCOUVER, Feb. 27, 2020 /CNW/ - The following issues have been halted by IIROC:
Feb 25, 2020 12:12 pm ET
Invictus Obtains Further Court Approvals in Connection with CCAA Proceedings
Vancouver, British Columbia--(Newsfile Corp. - February 25, 2020) - INVICTUS MD STRATEGIES CORP. (TSXV: GENE) (OTCQX: IVITF) (FSE: 8IS2) (the "Company") announces that on Monday, February 24, 2020, the Supreme Court of British Columbia (the "Court") granted an amended and restated initial order (the "Amended and Restated Initial Order") under the Companies' Creditors Arrangement Act (Canada) ("CCAA"). The Amended and Restated Initial Order also extends protection to Greener Pastures MD Ltd., Acreage Pharms Ltd. ("Acreage"), and 2015059 Alberta Ltd. (together with the Company, the "Invictus Group").
Feb 14, 2020 09:20 am ET
IIROC Trading Resumption - GENE
VANCOUVER, Feb. 14, 2020 /CNW/ - Trading resumes in:
Feb 13, 2020 03:55 pm ET
INVICTUS GRANTED CREDITOR PROTECTION AND WILL COMMENCE A STRATEGIC REVIEW
Invictus MD Strategies Corp. (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) (the “Company”) announced that on Thursday, February 13, 2020, the Supreme Court of British Columbia (the “Court”) issued an order granting the Company’s application for creditor...
Feb 13, 2020 07:46 am ET
IIROC Trading Halt - GENE
VANCOUVER, Feb. 13, 2020 /CNW/ - The following issues have been halted by IIROC:
Jan 03, 2020 10:46 am ET
INVICTUS ANNOUNCES TERMINATION OF THE PREVIOUSLY ANNOUNCED BINDING LETTER OF INTENT WITH UNIFIED CANNABIS CORP.
Vancouver, BC, January 3, 2020 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) further to the Company’s news release dated December 16, 2019, the Company has terminated the binding letter of intent...
Dec 16, 2019 08:33 am ET
INVICTUS ANNOUNCES $5,700,000 CONVERTIBLE DEBENTURE FINANCING
Vancouver, BC, December 16, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to announce that it has signed a binding letter of intent dated December 11, 2019 with Unified Cannabis...
Dec 13, 2019 05:00 pm ET
INVICTUS ANNOUNCES CHANGE TO BOARD
Vancouver, BC, December 13, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that Trevor Dixon has resigned from the Board of Directors of the Company effective immediately....
Dec 06, 2019 12:51 pm ET
INVICTUS ANNOUNCES RESIGNATIONS
Vancouver, BC, December 6, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that Messrs. Sparkes and Stein have resigned from the Board of Directors of the Company effective...
Dec 02, 2019 12:02 pm ET
INVICTUS ANNOUNCES THE RETURN OF TREVOR DIXON TO THE BOARD OF DIRECTORS
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces that Trevor Dixon is returning to the Board of Directors of the Company, his health issues having been resolved, effective today. Mr. Dixon...
Nov 25, 2019 08:22 am ET
INVICTUS CLOSES TERMINATION OF AUTHENTIC BRANDS GROUP LICENSE AGREEMENT
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company is pleased to announce the completion, effective September 30, 2019, of the previously announced termination of its license agreement with...
Nov 05, 2019 08:27 am ET
INVICTUS PROVIDES UPDATE ON ACREAGE PHARMS LTD. AND AB LABORATORIES INC.
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Marc Ripa, Interim Chief Executive Officer and Chief Operating Officer of Invictus, is pleased to report that the Company’s wholly owned subsidiary...
Oct 23, 2019 06:30 pm ET
INVICTUS AND AUTHENTIC BRANDS GROUP MUTUALLY AGREE TO TERMINATE LICENSE AGREEMENT
Vancouver, B.C., October 23, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) The Company and ABG-HMX, LLC (“ABG”) have mutually agreed to an early termination of the license agreement dated...
Oct 17, 2019 09:00 am ET
INVICTUS CLOSES SALE OF FUTURE HARVEST DEVELOPMENT LTD.
Vancouver, BC, October 17, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company is pleased to announce the completion, effective October 16, 2019, of the previously announced sale of...
Oct 08, 2019 09:00 am ET
INVICTUS ANNOUNCES APPOINTMENT OF INTERIM CEO AND ALTERNATE DIRECTOR
Vancouver, BC, October 8, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces that, due to health complications, Trevor Dixon, President, CEO and Director of the Company, is unable to...
Sep 24, 2019 09:00 am ET
INVICTUS CLOSES SALE OF 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS
Vancouver, BC, September 24, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) the Company is pleased to announce the completion of the previously announced sale of all of the Company’s...
Sep 20, 2019 12:07 pm ET
INVICTUS ENTERS INTO AGREEMENT TO SELL FUTURE HARVEST DEVELOPMENT LTD.
Vancouver, BC, September 20, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces that, the Company has agreed to sell the 82.5% issued and outstanding shares (the “Future Harvest...
Sep 11, 2019 09:00 am ET
INVICTUS ANNOUNCES AB LABORATORIES INC. RECEIVES AMENDED LICENSE
Vancouver, BC, September 11, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to announce that AB Laboratories Inc. (“AB Labs”) a company which is a 50% owned subsidiary of Invictus...
Aug 30, 2019 05:30 pm ET
INVICTUS SELLS 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS TO REDUCE OPERATIONAL COSTS AND STREAMLINE ITS OPERATIONS
Vancouver, BC, August 30, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces that, in accordance with the Company’s plan to reduce operational costs and streamline the Company’s...
Aug 27, 2019 05:25 pm ET
ACREAGE PHARMS LTD. SIGNS NON-BINDING TERM SHEET FOR UP TO $6 MILLION FINANCING FROM TRICHOME FINANCIAL
Vancouver, BC, August 27, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that Acreage Pharms Ltd. ("Acreage"), the Company's wholly-owned subsidiary, has signed a...
Aug 19, 2019 12:51 pm ET
Invictus MD Strategies Corp. Opens the Market
TORONTO, Aug. 19, 2019 /CNW/ - Trevor Dixon, Chief Executive Officer, Invictus MD Strategies Corp. (GENE), joined Steven Mills, Head, Company Services, Toronto Stock Exchange and TSX Venture Exchange, to open the market. Invictus MD Strategies Corp. is a global cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the Company's medical clients and retail customers. Invictus MD Strategies Corp. commenced trading on TSX Venture Exchange on March 31, 2017.
Aug 14, 2019 09:00 am ET
ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE
Vancouver, BC, August 14, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that Acreage Pharms Ltd. (“Acreage”),...
Aug 12, 2019 09:00 am ET
GENE SIMMONS ABDICATES ROLE AS CHIEF EVANGELIST OFFICER FOR INVICTUS
INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that rock icon and marketing and branding innovator Gene Simmons has abdicated his position as the Company’s Chief Evangelist Officer....
Aug 06, 2019 09:00 am ET
ACREAGE PHARMS LTD. ACHIEVES SUBSTANTIAL COMPLETION OF 90,000 SQUARE FOOT PHASE III FACILITY
Vancouver, BC, August 6, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that Acreage Pharms Ltd. (“Acreage”),...
Jul 25, 2019 03:03 pm ET
Invictus announces Annual General Meeting Results
Vancouver, BC, July 25, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to report that at the Company’s Annual General Meeting (the “Meeting”) held today in Vancouver,...
Jul 09, 2019 09:52 am ET
Invictus announces Closing of Non-Brokered Private Placement
Vancouver, BC, July 9, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces it has closed the non-brokered private placement consisting of 1,250,000 units at a price of $0.40 per unit...
Jul 03, 2019 09:00 am ET
Invictus announces Non-Brokered Private Placement
Vancouver, BC, July 3, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces it has negotiated a non-brokered private placement consisting of 1,250,000 units at a price of $0.40 per...
Jul 02, 2019 09:00 am ET
INVICTUS ANNOUNCES AB VENTURES INC. UPDATE
Vancouver, BC, July 2, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that AB Ventures Inc. (“AB Ventures”), a...
Jun 28, 2019 09:00 am ET
INVICTUS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS
Vancouver, BC, June 28, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) today reported financial results for the first quarter ended April 30, 2019. “We are pleased with the progress on...
Jun 26, 2019 09:44 am ET
INVICTUS ANNOUNCES AB LABORATORIES INC. UPDATE
Vancouver, BC, June 26, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that AB Laboratories Inc. (“AB Labs”), a...
Jun 20, 2019 09:00 am ET
Invictus announces Annual General Meeting Date
Vancouver, BC, June 20, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company is pleased to announce that the annual general meeting of the shareholders of the Company will be held on...
Jun 12, 2019 09:15 am ET
UPDATE ON ACREAGE PHARMS LTD.
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) Mr. Trevor Dixon, Chief Executive Officer of Invictus, is pleased to report that the Phase I and II facilities of the Company’s wholly owned subsidiary...
Jun 11, 2019 09:12 am ET
INVICTUS ANNOUNCES APPOINTMENT TO BOARD
Vancouver, BC, June 11, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that Mr. Colin Kinsley has been appointed to the Board of Directors as an independent Director. Mr....
Jun 05, 2019 09:00 am ET
INVICTUS ANNOUNCES EXECUTIVE APPOINTMENT
Vancouver, BC, June 5, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that Mr. Marc Ripa has been appointed Chief Operating Officer (“COO”) of the Company. Mr. Ripa is...
Jun 04, 2019 09:00 am ET
INVICTUS ANNOUNCES CHANGES TO BOARD
Vancouver, BC, June 4, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that Mr. Richard Lee has been appointed to the Board of Directors as an independent Director. Mr....
May 31, 2019 05:30 pm ET
INVICTUS ANNOUNCES CHANGE TO MANAGEMENT AND BOARD
Vancouver, BC, May 31, 2019 - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announces that the Board of Directors (the “Board”) has accepted Mr. George E. Kveton’s resignation as Chief Executive...
May 15, 2019 09:00 am ET
Invictus Withdraws Plans for NASDAQ Listing and Related Share Consolidation
Vancouver, BC, May 15, 2019 – INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) announced today that the Company is withdrawing plans to list the Company’s common shares (the “Shares”) on NASDAQ Stock...
May 09, 2019 09:00 am ET
Invictus Announces Appointment of Director and Chief Operating Officer
VANCOUVER, May 9, 2019 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company is pleased to announce the appointment of Trevor Dixon as a Director and Chief Operating Officer of the Company effective immediately. Mr. Dixon is the founder, President and Chief Executive Officer of the Company's wholly owned subsidiary Acreage Pharms Ltd. ("Acreage Pharms").
May 09, 2019 09:00 am ET
Invictus Announces Appointment of Director and Chief Operating Officer
VANCOUVER, May 9, 2019 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) the Company is pleased to announce the appointment of Trevor Dixon as a Director and Chief Operating Officer of the Company effective immediately. Mr. Dixon is the founder, President and Chief Executive Officer of the Company's wholly owned subsidiary Acreage Pharms Ltd. ("Acreage Pharms").
Apr 26, 2019 04:00 pm ET
INVICTUS GRANTS OPTIONS
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) the Company has granted 200,000 incentive stock options to certain officers, directors and other eligible persons of the Company. The options are...
Apr 23, 2019 09:10 am ET
Invictus To Develop CBD-Infused Sodas with Rock Icon Gene Simmons and Simmons’ Moneybag™ Sodas
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS2) announced today that it has entered into a letter of intent (“LOI”) to form a Joint Venture (“JV”) with Gene Simmons (“Simmons”), Simmons’ MoneyBag Sodas...
Apr 01, 2019 10:23 am ET
INVICTUS MAKES FIRST SHIPMENT TO ONTARIO CANNABIS STORE
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS2) is pleased to have made its inaugural shipment to the Ontario Cannabis Store, marking the Company’s entrance to Canada’s largest market. Adult...
Mar 25, 2019 02:48 pm ET
GENE SIMMONS TAKES INVICTUS ON TOUR
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to report that the Company’s Chief Evangelist Officer Gene Simmons is taking Invictus with him on the KISS End of the Road Tour. The rock...
Mar 22, 2019 09:57 am ET
AB LABS AWARDED SALES LICENSE
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that the Company’s licensed producer AB Labs Inc. (“AB Labs") has received a medical sales and processing license from Health...
Mar 15, 2019 09:14 am ET
INVICTUS ANNOUNCES APPOINTMENT OF NEW CFO
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce the appointment of Harbir Toor as Chief Financial Officer (“CFO”) on March 7, 2019, to succeed Dylan Easterbrook. Ms. Toor...
Mar 07, 2019 03:05 pm ET
INVICTUS AND CANNAMERICA PROVIDE UPDATE ON HEMP AND CBD JOINT VENTURE
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to provide an update on its binding letter of intent to create a joint venture with Cannamerica Brands Corp. (CSE: CANA) (OTCQB: CNNXF) and...
Mar 04, 2019 09:49 am ET
INVICTUS PROVIDES PROGRESS UPDATE ON LICENSED PRODUCER EXPANSION
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to provide an update on production and expansion plans at its Licensed Producers: Acreage Pharms Ltd. (“Acreage Pharms”), AB Laboratories...
Feb 25, 2019 01:16 pm ET
INVICTUS PROVIDES UPDATE ON OIL EXTRACTION PROGRAM
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has successfully completed testing on two batches of...
Feb 13, 2019 09:01 am ET
INVICTUS SECURES SUPPLY AGREEMENT WITH THE ONTARIO CANNABIS RETAIL CORPORATION
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has signed an agreement to supply the Ontario Cannabis...
Feb 12, 2019 08:30 pm ET
INVICTUS HIRES INTERIM CHIEF MARKETING OFFICER AND EXPANDS INVESTOR RELATIONS
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has hired a prominent Toronto based strategic consulting agency (the “Agency”) as interim Chief Marketing Officer...
Jan 29, 2019 08:00 am ET
CBD Gummies In High Demand; International Spirits and Beverage Group (OTC: ISBG), Invictus MD Strategies, CV Sciences and Canopy Growth
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks, releases a snapshot focused on the CBD edibles market and how, specifically, CBD gummies are in high demand. CBD gummies landed on Google's ‘Year in Search...
Jan 28, 2019 08:00 am ET
CannAmerica and Invictus Provide Update on Hemp and CBD Joint Venture
VANCOUVER, Jan. 28, 2019 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to provide an update on its binding letter of intent ("LOI") to create a joint venture with Cannamerica Brands Corp. ("CannAmerica") (CSE: CANA) (OTCQB: CNNXF) and CBDistribution Company Ltd. ("CBDC") (collectively the "Joint Venture") that was previously announced on January 7, 2019 with the intention of acquiring hemp biomass for extraction into CBD isolate using purpose-built facilities for large scale CBD extraction.
Jan 28, 2019 08:00 am ET
CannAmerica and Invictus Provide Update on Hemp and CBD Joint Venture
VANCOUVER, Jan. 28, 2019 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to provide an update on its binding letter of intent ("LOI") to create a joint venture with Cannamerica Brands Corp. ("CannAmerica") (CSE: CANA) (OTCQB: CNNXF) and CBDistribution Company Ltd. ("CBDC") (collectively the "Joint Venture") that was previously announced on January 7, 2019 with the intention of acquiring hemp biomass for extraction into CBD isolate using purpose-built facilities for large scale CBD extraction.
Jan 21, 2019 12:16 pm ET
Update: Invictus Nasdaq application and share consolidation
VANCOUVER, Jan. 21, 2019 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announced today an update to its intention to proceed with a consolidation of its issued and outstanding shares with a newly proposed reduced share consolidation ratio of one new share for every five old shares (1:5) in connection with its proposed listing on Nasdaq Stock Market LLC ("Nasdaq"). The proposed reduced share consolidation ratio replaces the original consideration on the basis of one new share for seven old shares (1:7) (see press release dated January
Jan 21, 2019 12:16 pm ET
Update: Invictus Nasdaq application and share consolidation
VANCOUVER, Jan. 21, 2019 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announced today an update to its intention to proceed with a consolidation of its issued and outstanding shares with a newly proposed reduced share consolidation ratio of one new share for every five old shares (1:5) in connection with its proposed listing on Nasdaq Stock Market LLC ("Nasdaq"). The proposed reduced share consolidation ratio replaces the original consideration on the basis of one new share for seven old shares (1:7) (see press release dated
Jan 21, 2019 11:32 am ET
Invictus' Canandia Awarded Sales License
VANCOUVER, Jan. 21, 2019 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that the Company's wholly-owned subsidiary 0989561 B.C. Ltd. ("Canandia") has received a sales license for its Delta location (the "Delta Facility") from Health Canada effective January 18, 2019, pursuant to the Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Delta Facility includes a cultivation, production and research facility, designed to highlight our capabilities as producers and breeders of superior cannabis strains
Jan 21, 2019 11:32 am ET
Invictus' Canandia Awarded Sales License
VANCOUVER, Jan. 21, 2019 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that the Company's wholly-owned subsidiary 0989561 B.C. Ltd. ("Canandia") has received a sales license for its Delta location (the "Delta Facility") from Health Canada effective January 18, 2019, pursuant to the Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Delta Facility includes a cultivation, production and research facility, designed to highlight our capabilities as producers and breeders of superior cannabis
Jan 18, 2019 08:39 am ET
Invictus Executives to Represent Cannabis at World Economic Forum in Davos, Switzerland January 23 at 4pm GMT
VANCOUVER, Jan. 17, 2019 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that George E. Kveton, President and CEO of Invictus, and Paul Sparkes, Chairman of Invictus, will attend CannaTech at the World Economic Forum in Davos, Switzerland for a panel discussion entitled How to Build International Brands in the Cannabis Industry on Wednesday, January 23, 2019 at 4:00 p.m. GMT. Invicuts will present alongside top international cannabis industry leaders including Bruce Linton, CEO of Canopy Growth Corporation ("Cano
Jan 18, 2019 08:39 am ET
Invictus Executives to Represent Cannabis at World Economic Forum in Davos, Switzerland January 23 at 4pm GMT
VANCOUVER, Jan. 17, 2019 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that George E. Kveton, President and CEO of Invictus, and Paul Sparkes, Chairman of Invictus, will attend CannaTech at the World Economic Forum in Davos, Switzerland for a panel discussion entitled How to Build International Brands in the Cannabis Industry on Wednesday, January 23, 2019 at 4:00 p.m. GMT. Invicuts will present alongside top international cannabis industry leaders including Bruce Linton, CEO of Canopy Growth Corporation
Jan 17, 2019 08:00 am ET
Invictus MD Announces Submission of Its Application to List on NASDAQ and Share Consolidation
VANCOUVER, Jan. 17, 2019 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has submitted its application to list its common shares (the "Shares") on the NASDAQ Capital Market ("NASDAQ"). In advance of listing on NASDAQ, the Company will file a Form 40-F Registration Statement with the United States Securities and Exchange Commission. The listing of the Company's Shares on NASDAQ remains subject to the approval of NASDAQ and the satisfaction of all applicable listing and regulatory requirements, including th
Jan 17, 2019 08:00 am ET
Invictus MD Announces Submission of Its Application to List on NASDAQ and Share Consolidation
VANCOUVER, Jan. 17, 2019 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has submitted its application to list its common shares (the "Shares") on the NASDAQ Capital Market ("NASDAQ"). In advance of listing on NASDAQ, the Company will file a Form 40-F Registration Statement with the United States Securities and Exchange Commission. The listing of the Company's Shares on NASDAQ remains subject to the approval of NASDAQ and the satisfaction of all applicable listing and regulatory requirements, inclu
Jan 16, 2019 09:36 am ET
IIROC Trading Resumption - GENE; GENE.WT
VANCOUVER, Jan. 16, 2019 /CNW/ - Trading resumes in:
Jan 16, 2019 09:30 am ET
Cannamerica and Invictus Provide Update on Hemp and CBD Joint Venture
VANCOUVER, Jan. 16, 2019 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to provide an update on its binding letter of intent ("LOI") to create a joint venture with Cannamerica Brands Corp. ("CannAmerica") (CSE: CANA) (OTCQB: CNNXF) and CBDistribution Company Ltd. ("CBDC") (collectively the "Joint Venture") that was previously announced on January 7, 2019 with the intention of acquiring hemp biomass for extraction into CBD isolate using purpose-built facilities for large scale CBD extraction.
Jan 16, 2019 09:30 am ET
Cannamerica and Invictus Provide Update on Hemp and CBD Joint Venture
VANCOUVER, Jan. 16, 2019 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to provide an update on its binding letter of intent ("LOI") to create a joint venture with Cannamerica Brands Corp. ("CannAmerica") (CSE: CANA) (OTCQB: CNNXF) and CBDistribution Company Ltd. ("CBDC") (collectively the "Joint Venture") that was previously announced on January 7, 2019 with the intention of acquiring hemp biomass for extraction into CBD isolate using purpose-built facilities for large scale CBD extraction.
Jan 16, 2019 08:30 am ET
IIROC Trading Halt - GENE
VANCOUVER, Jan. 16, 2019 /CNW/ - The following issues have been halted by IIROC:
Jan 15, 2019 04:00 pm ET
Invictus And GTEC Holdings Announce Formal Termination of Merger Plans and Maintain Existing Working Relationship
VANCOUVER, Jan. 15, 2019 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announced that pursuant to the terms of a non-binding letter of intent (the "LOI") entered into with GTEC Holdings Ltd. (TSXV: GTEC; OTC:GGTTF) ("GTEC"), as announced on November 16, 2018, the parties have mutually agreed to terminate the LOI and not proceed with the merger, with a preference for increased strategic collaboration in building out the route to adult consumer retail side.
Jan 15, 2019 04:00 pm ET
Invictus And GTEC Holdings Announce Formal Termination of Merger Plans and Maintain Existing Working Relationship
VANCOUVER, Jan. 15, 2019 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announced that pursuant to the terms of a non-binding letter of intent (the "LOI") entered into with GTEC Holdings Ltd. (TSXV: GTEC; OTC:GGTTF) ("GTEC"), as announced on November 16, 2018, the parties have mutually agreed to terminate the LOI and not proceed with the merger, with a preference for increased strategic collaboration in building out the route to adult consumer retail side.
Jan 15, 2019 03:30 am ET
Keith Stein Replaces Trevor Dixon and Josef Hocher on Invictus' Board
VANCOUVER, Jan. 15, 2019 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that the Company's Board of Directors (the "Board") has approved the appointment of Keith Stein, Counsel at Dentons Canada LLP ("Dentons"), to serve on the Board effective January 11, 2019. The new appointment follows the resignations of Trevor Dixon, President and Director of Invictus since April 25, 2017, and Josef Hocher, member of the Board since June 26, 2017. Mr. Dixon will remain as President and Director of the Company's wholly-owned
Jan 15, 2019 03:30 am ET
Keith Stein Replaces Trevor Dixon and Josef Hocher on Invictus' Board
VANCOUVER, Jan. 15, 2019 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that the Company's Board of Directors (the "Board") has approved the appointment of Keith Stein, Counsel at Dentons Canada LLP ("Dentons"), to serve on the Board effective January 11, 2019. The new appointment follows the resignations of Trevor Dixon, President and Director of Invictus since April 25, 2017, and Josef Hocher, member of the Board since June 26, 2017. Mr. Dixon will remain as President and Director of the Company's wholl
Jan 07, 2019 08:00 am ET
Invictus and CannAmerica Combine to Enter Hemp and CBD Market in the US
VANCOUVER, Jan. 7, 2019 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a binding letter of intent ("LOI") to create a joint venture with Cannamerica Brands Corp. ("CannAmerica") (CSE: CANA) (OTCQB: CNNXF) and CBDistribution Company Ltd. ("CBDC") with the intention of acquiring hemp biomass for extraction into CBD isolate using purpose-built facilities for large scale CBD extraction.
Jan 07, 2019 08:00 am ET
Invictus and CannAmerica Combine to Enter Hemp and CBD Market in the US
VANCOUVER, Jan. 7, 2019 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a binding letter of intent ("LOI") to create a joint venture with Cannamerica Brands Corp. ("CannAmerica") (CSE: CANA) (OTCQB: CNNXF) and CBDistribution Company Ltd. ("CBDC") with the intention of acquiring hemp biomass for extraction into CBD isolate using purpose-built facilities for large scale CBD extraction.
Dec 20, 2018 07:55 am ET
Invictus signs five-year 10,000 kg supply agreement with Deutsche Medizinalcannabis in Germany
VANCOUVER, Dec. 20, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that its wholly-owned licensed producer, Acreage Pharms Ltd. ("Acreage Pharms"), has entered into a five-year supply and distribution agreement with Deutsche Medizinalcannabis GmbH ("Deutsche Medizinalcannabis") for a total of 10,000 kgs of dried cannabis flower. Deutsche Medizinalcannabis is an importer and distributor of medical cannabis in Germany with a vast distribution network and direct access to 20,000 pharmacies and a clear focus on
Dec 20, 2018 07:55 am ET
Invictus signs five-year 10,000 kg supply agreement with Deutsche Medizinalcannabis in Germany
VANCOUVER, Dec. 20, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that its wholly-owned licensed producer, Acreage Pharms Ltd. ("Acreage Pharms"), has entered into a five-year supply and distribution agreement with Deutsche Medizinalcannabis GmbH ("Deutsche Medizinalcannabis") for a total of 10,000 kgs of dried cannabis flower. Deutsche Medizinalcannabis is an importer and distributor of medical cannabis in Germany with a vast distribution network and direct access to 20,000 pharmacies and a clear f
Dec 03, 2018 04:36 pm ET
Invictus Advances $500,000 on Convertible Loan Facility
VANCOUVER, Dec. 3, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that pursuant to the Loan Agreement with GTEC Holdings Ltd. (TSXV: GTEC; OTC: GGTTF) ("GTEC") dated October 17, 2018, as amended on October 19, 2018 and on November 21, 2018 (the "Agreement"), as announced on November 16, 2018, it has completed the draw-down of $500,000 of convertible debt. Pursuant to the Agreement, the Company has drawn down the aggregate of $2.5 million convertible debt (the "Convertible Debt"), evidenced by way of a Conve
Dec 03, 2018 04:36 pm ET
Invictus Advances $500,000 on Convertible Loan Facility
VANCOUVER, Dec. 3, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that pursuant to the Loan Agreement with GTEC Holdings Ltd. (TSXV: GTEC; OTC: GGTTF) ("GTEC") dated October 17, 2018, as amended on October 19, 2018 and on November 21, 2018 (the "Agreement"), as announced on November 16, 2018, it has completed the draw-down of $500,000 of convertible debt. Pursuant to the Agreement, the Company has drawn down the aggregate of $2.5 million convertible debt (the "Convertible Debt"), evidenced by way of
Nov 26, 2018 07:37 am ET
Invictus provides online access to letter of transmittal for Poda spinout
VANCOUVER, Nov. 26, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces that further to the completion of the plan of arrangement to give effect to the spinout transaction (the "Arrangement") involving Invictus and Poda Technologies Ltd. ("Poda") on November 8, 2018, Computershare Investor Services Inc. (the "Depositary") has mailed to each registered Invictus shareholder a letter of transmittal containing instructions for use in exchanging their Invictus common share certificates for certificates representing the post-Arran
Nov 26, 2018 07:37 am ET
Invictus provides online access to letter of transmittal for Poda spinout
VANCOUVER, Nov. 26, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces that further to the completion of the plan of arrangement to give effect to the spinout transaction (the "Arrangement") involving Invictus and Poda Technologies Ltd. ("Poda") on November 8, 2018, Computershare Investor Services Inc. (the "Depositary") has mailed to each registered Invictus shareholder a letter of transmittal containing instructions for use in exchanging their Invictus common share certificates for certificates representing the pos
Nov 16, 2018 09:13 am ET
IIROC Trading Resumption - GTEC; GENE
VANCOUVER, Nov. 16, 2018 /CNW/ - Trading resumes in:
Nov 16, 2018 08:39 am ET
IIROC Trading Halt - GTEC; GENE
VANCOUVER, Nov. 16, 2018 /CNW/ - The following issues have been halted by IIROC:
Nov 16, 2018 08:30 am ET
Invictus announces strategic merger with GTEC Holdings forming Western Canada's largest indoor vertically integrated cannabis company
VANCOUVER, Nov. 16, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a non-binding Letter of Intent (the "Agreement") with GTEC Holdings Ltd. (TSXV:GTEC) (OTC:GGTTF) ("GTEC") for the acquisition by Invictus of all of the issued and outstanding shares in the capital of GTEC in an all-share transaction valued at approximately $100 million (the "Transaction"), forming Western Canada's largest indoor vertically integrated cannabis companies.
Nov 16, 2018 08:30 am ET
Invictus announces strategic merger with GTEC Holdings forming Western Canada's largest indoor vertically integrated cannabis company
VANCOUVER, Nov. 16, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a non-binding Letter of Intent (the "Agreement") with GTEC Holdings Ltd. (TSXV:GTEC) (OTC:GGTTF) ("GTEC") for the acquisition by Invictus of all of the issued and outstanding shares in the capital of GTEC in an all-share transaction valued at approximately $100 million (the "Transaction"), forming Western Canada's largest indoor vertically integrated cannabis companies.
Nov 16, 2018 08:00 am ET
Invictus Completes Acquisition of Canandia in British Columbia, its Third Licensed Cultivation Facility Under the Cannabis Act & Cannabis Regulations
VANCOUVER, Nov. 16, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has successfully exercised its option to acquire 100% (the "Option") of the outstanding shares of 0989561 B.C. Ltd. ("Canandia") from its current shareholders (see press releases dated: May 16, 2018, July 18, 2018 and October 15, 2018, for more details).
Nov 16, 2018 08:00 am ET
Invictus Completes Acquisition of Canandia in British Columbia, its Third Licensed Cultivation Facility Under the Cannabis Act & Cannabis Regulations
VANCOUVER, Nov. 16, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has successfully exercised its option to acquire 100% (the "Option") of the outstanding shares of 0989561 B.C. Ltd. ("Canandia") from its current shareholders (see press releases dated: May 16, 2018, July 18, 2018 and October 15, 2018, for more details).
Nov 13, 2018 09:46 am ET
New Green Frontier 2018; Gravitas Financial Inc.’s inaugural cannabis investor conference announces Gene Simmons as keynote speaker
Today, New Green Frontier, an invite-only, cannabis investor conference, is pleased to announce that Gene Simmons, legendary rock star, Chief Evangelist Officer of Invictus-MD (TSXV: GENE, OTC: IVITF) will be the keynote speaker for this year's...
Nov 09, 2018 03:30 am ET
Invictus and Poda announce closing of arrangement
VANCOUVER, Nov. 9, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) and Poda Technologies Ltd. ("Poda") are pleased to announce the completion of the plan of arrangement to give effect to the spinout transaction (the "Arrangement"), as previously announced on August 21, 2018. The arrangement agreement between Invictus and Poda dated September 10, 2018, sets out the terms of the Arrangement. The Arrangement was voted on and approved by the Company's shareholders at its 2018 Annual General and Special Meeting of Shareholders, held on
Nov 09, 2018 03:30 am ET
Invictus and Poda announce closing of arrangement
VANCOUVER, Nov. 9, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) and Poda Technologies Ltd. ("Poda") are pleased to announce the completion of the plan of arrangement to give effect to the spinout transaction (the "Arrangement"), as previously announced on August 21, 2018. The arrangement agreement between Invictus and Poda dated September 10, 2018, sets out the terms of the Arrangement. The Arrangement was voted on and approved by the Company's shareholders at its 2018 Annual General and Special Meeting of Shareholders,
Nov 05, 2018 03:11 am ET
Invictus Announces New Go Forward Leadership Team
Vancouver, BC / TheNewswire /
November 5, 2018 - INVICTUS MD STRATEGIES CORP. ("Invictus"
or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA:
8IS1) announced today the resignation of Dan
Kriznic as CEO and Chairman of the Company, effective immediately.
Kriznic will remain with the Company as an advisor to the new Chairman
and CEO. Kriznic commented "I co-founded Invictus in 2014 with
the vision of creating a global cannabis company. To date, we have
raised over $125 million and deployed capital into the acquisition of
licenses and the construction of advanced commercial cultivation
facilities.
Nov 02, 2018 04:30 am ET
Invictus Completes Leaf Wise Acquisition
VANCOUVER, Nov. 2, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) today announced the completion of its previously announced definitive agreement to acquire 100% (the "Acquisition") of the issued and outstanding shares of a company ("Leaf Wise") that operates medical clinics in Alberta (see press releases dated July 20, 2018 and October 25, 2018 for more details). The Acquisition was approved by the Board and TSXV on October 31, 2018.
Nov 02, 2018 04:30 am ET
Invictus Completes Leaf Wise Acquisition
VANCOUVER, Nov. 2, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) today announced the completion of its previously announced definitive agreement to acquire 100% (the "Acquisition") of the issued and outstanding shares of a company ("Leaf Wise") that operates medical clinics in Alberta (see press releases dated July 20, 2018 and October 25, 2018 for more details). The Acquisition was approved by the Board and TSXV on October 31, 2018.
Oct 25, 2018 04:30 am ET
Invictus Signs Definitive Agreement with Clinic Servicing 3,400 ACMPR Registered Patients
VANCOUVER, Oct. 25, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a definitive agreement to acquire 100% (the "Acquisition") of the issued and outstanding shares of a company ("Leaf Wise") that operates medical clinics in Alberta (see press release dated July 20, 2018, for more details).
Oct 25, 2018 04:30 am ET
Invictus Signs Definitive Agreement with Clinic Servicing 3,400 ACMPR Registered Patients
VANCOUVER, Oct. 25, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a definitive agreement to acquire 100% (the "Acquisition") of the issued and outstanding shares of a company ("Leaf Wise") that operates medical clinics in Alberta (see press release dated July 20, 2018, for more details).
Oct 23, 2018 04:00 pm ET
Invictus Completes Advance on $2 Million Convertible Loan Facility
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES/
Oct 19, 2018 04:00 pm ET
Invictus Announces Shareholders Voting Results of Annual General and Special Meeting
VANCOUVER, Oct. 19, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces the following voting results from the Company's 2018 Annual General and Special Meeting of Shareholders (the "Meeting"), which was held in Vancouver on October 18, 2018. A total of 37,280,226 common shares of the 96,623,857 common shares outstanding at the record date were voted at the Meeting, representing 38.58% of the issued and outstanding common shares of the Company at the record date.
Oct 19, 2018 04:00 pm ET
Invictus Announces Shareholders Voting Results of Annual General and Special Meeting
VANCOUVER, Oct. 19, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces the following voting results from the Company's 2018 Annual General and Special Meeting of Shareholders (the "Meeting"), which was held in Vancouver on October 18, 2018. A total of 37,280,226 common shares of the 96,623,857 common shares outstanding at the record date were voted at the Meeting, representing 38.58% of the issued and outstanding common shares of the Company at the record date.
Oct 19, 2018 11:39 am ET
Invictus Signs Agreement with GTEC to Support Cannabis Retail Expansion
VANCOUVER, Oct. 19, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a definitive agreement (the "Definitive Agreement") with GTEC Holdings Ltd. ("GTEC") (TSXV: GTEC; OTCPK: GGTTF) for the previously announced non-revolving unsecured convertible loan (the "Loan Facility") in an amount up to $2,000,000, and an interest rate of 8% (see press release dated August 30, 2018, for more details). The proceeds from the Loan Facility will be used by GTEC for the expansion and development of its
Oct 19, 2018 11:39 am ET
Invictus Signs Agreement with GTEC to Support Cannabis Retail Expansion
VANCOUVER, Oct. 19, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a definitive agreement (the "Definitive Agreement") with GTEC Holdings Ltd. ("GTEC") (TSXV: GTEC; OTCPK: GGTTF) for the previously announced non-revolving unsecured convertible loan (the "Loan Facility") in an amount up to $2,000,000, and an interest rate of 8% (see press release dated August 30, 2018, for more details). The proceeds from the Loan Facility will be used by GTEC for the expansion and development
Oct 19, 2018 09:59 am ET
Invictus Completes $23 Million Bought Deal Financing
/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
Oct 15, 2018 09:46 am ET
Invictus announces OptionCo has received its license to cultivate
VANCOUVER, Oct. 15, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that OptionCo's Delta Facility, located in British Columbia, has received its license to cultivate cannabis under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), effective October 12, 2018.
Oct 15, 2018 09:46 am ET
Invictus announces OptionCo has received its license to cultivate
VANCOUVER, Oct. 15, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that OptionCo's Delta Facility, located in British Columbia, has received its license to cultivate cannabis under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), effective October 12, 2018.
Oct 12, 2018 05:00 pm ET
Wayland Group Comments on Recent Promotional Market Activity
Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) wishes to make the following statements regarding recent market activity in its common shares traded on the OTCQB marketplace. The Company has been asked to issue...
Oct 01, 2018 04:30 am ET
Invictus CEO Dan Kriznic to Present at Cannabis Invest Europe
VANCOUVER, Oct. 1, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that the Company's Chairman and CEO, Dan Kriznic, will be presenting at Cannabis Invest, the UK and Europe's leading cannabis investment conference, in London on October 2, 2018, and in Geneva on October 3, 2018.
Oct 01, 2018 04:30 am ET
Invictus CEO Dan Kriznic to Present at Cannabis Invest Europe
VANCOUVER, Oct. 1, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that the Company's Chairman and CEO, Dan Kriznic, will be presenting at Cannabis Invest, the UK and Europe's leading cannabis investment conference, in London on October 2, 2018, and in Geneva on October 3, 2018.
Sep 26, 2018 07:51 am ET
Invictus Announces $20 Million Equity Financing
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announces that it has entered into an agreement with PI Financial Corp. and GMP Securities L.P. as co-lead underwriters on behalf of a syndicate of...
Sep 25, 2018 08:00 am ET
Invictus' Acreage Pharms Completes Shipment of Recreational Cannabis to British Columbia
VANCOUVER, Sept. 25, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to have completed its first shipment of recreational cannabis to British Columbia on time, following its inaugural shipment to Alberta. Staff have been working around the clock to meet aggressive deadlines set to ensure Invictus products are available to adult consumers on October 17, 2018.
Sep 25, 2018 08:00 am ET
Invictus' Acreage Pharms Completes Shipment of Recreational Cannabis to British Columbia
VANCOUVER, Sept. 25, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to have completed its first shipment of recreational cannabis to British Columbia on time, following its inaugural shipment to Alberta. Staff have been working around the clock to meet aggressive deadlines set to ensure Invictus products are available to adult consumers on October 17, 2018.
Sep 24, 2018 09:00 am ET
Invictus Provides Update on German Partnership and EU-GMP Certification
VANCOUVER, Sept. 24, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE) (OTCQX: IVITF) (FRA: 8IS1) is pleased to provide an update on its progress towards European Union Good Manufacturing Practices ("EU-GMP") certification. Invictus' wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has designed and is currently building its Phase 3 and 4 purpose-built cultivation facilities to be EU-GMP compliant. EU-GMP standards are the most stringent regulations in the world and our team at Acreage Pharms are working together with professional consultants
Sep 24, 2018 09:00 am ET
Invictus Provides Update on German Partnership and EU-GMP Certification
VANCOUVER, Sept. 24, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE) (OTCQX: IVITF) (FRA: 8IS1) is pleased to provide an update on its progress towards European Union Good Manufacturing Practices ("EU-GMP") certification. Invictus' wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has designed and is currently building its Phase 3 and 4 purpose-built cultivation facilities to be EU-GMP compliant. EU-GMP standards are the most stringent regulations in the world and our team at Acreage Pharms are working together with professional cons
Sep 17, 2018 04:30 am ET
Invictus Hires Ex-Heineken Executive Kevin Smith as VP Recreational Sales; Sarah Hardy as VP Medical Sales
Invictus hires former Heineken executive Kevin Smith as VP Recreational Sales
Sep 17, 2018 04:30 am ET
Invictus Hires Ex-Heineken Executive Kevin Smith as VP Recreational Sales; Sarah Hardy as VP Medical Sales
Invictus hires former Heineken executive Kevin Smith as VP Recreational Sales
Sep 11, 2018 10:57 am ET
Invictus' Acreage Pharms to Become a Registered Cannabis Supplier in Saskatchewan
VANCOUVER, Sept. 11, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE) (OTCQX: IVITF) (FRA: 8IS1) is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has been granted conditional approval to become a registered supplier with the Saskatchewan Liquor and Gaming Authority ("SLGA") once legislation is implemented on October 17, 2018. In the interim, and subject to any federal restrictions, Acreage Pharms is eligible to supply product to authorized provincial wholesalers and retailers in advance of October 17.
Sep 11, 2018 10:57 am ET
Invictus' Acreage Pharms to Become a Registered Cannabis Supplier in Saskatchewan
VANCOUVER, Sept. 11, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE) (OTCQX: IVITF) (FRA: 8IS1) is pleased to announce that its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has been granted conditional approval to become a registered supplier with the Saskatchewan Liquor and Gaming Authority ("SLGA") once legislation is implemented on October 17, 2018. In the interim, and subject to any federal restrictions, Acreage Pharms is eligible to supply product to authorized provincial wholesalers and retailers in advance of October 17.
Sep 11, 2018 04:30 am ET
Invictus Signs Arrangement Agreement for Spinout of Poda and Announces Annual General and Special Meeting Date
VANCOUVER, Sept. 11, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announced today that it has entered into a non-arm's length arrangement agreement dated September 10, 2018 (the "Agreement"), with Poda Technologies Inc. ("Poda") to give effect to the spin-out transaction previously announced on August 21, 2018.
Sep 11, 2018 04:30 am ET
Invictus Signs Arrangement Agreement for Spinout of Poda and Announces Annual General and Special Meeting Date
VANCOUVER, Sept. 11, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) announced today that it has entered into a non-arm's length arrangement agreement dated September 10, 2018 (the "Agreement"), with Poda Technologies Inc. ("Poda") to give effect to the spin-out transaction previously announced on August 21, 2018.
Sep 07, 2018 12:01 pm ET
Invictus Acreage Pharms Makes First Provincial Bulk Shipment of Recreational Cannabis on Schedule
VANCOUVER, Sept. 7, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to have completed its first shipment of recreational cannabis under Provincial supply agreement on schedule, ensuring quality product for opening day on October 17, 2018. Staff have been working 24 hours per day, seven days a week to package product in order to meet this ambitious deadline.
Sep 07, 2018 12:01 pm ET
Invictus Acreage Pharms Makes First Provincial Bulk Shipment of Recreational Cannabis on Schedule
VANCOUVER, Sept. 7, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to have completed its first shipment of recreational cannabis under Provincial supply agreement on schedule, ensuring quality product for opening day on October 17, 2018. Staff have been working 24 hours per day, seven days a week to package product in order to meet this ambitious deadline.
Sep 06, 2018 04:30 am ET
Invictus Closes $25.5 Million Debt Financing from ATB Financial
VANCOUVER, Sept. 6, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has closed the previously disclosed $25.5 million debt financing arrangement (the "Financing") with ATB Financial ("ATB") (see press release dated August 8, 2018, for further details). The Financing will be used to accelerate the construction of its Phase 3 and Phase 4 cannabis cultivation facilities (the "Expansion Plan") at Acreage Pharms Ltd. ("Acreage Pharms"), located in West-Central Alberta. The Expansion Plan will add a total
Sep 06, 2018 04:30 am ET
Invictus Closes $25.5 Million Debt Financing from ATB Financial
VANCOUVER, Sept. 6, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has closed the previously disclosed $25.5 million debt financing arrangement (the "Financing") with ATB Financial ("ATB") (see press release dated August 8, 2018, for further details). The Financing will be used to accelerate the construction of its Phase 3 and Phase 4 cannabis cultivation facilities (the "Expansion Plan") at Acreage Pharms Ltd. ("Acreage Pharms"), located in West-Central Alberta. The Expansion Plan will add a
Sep 05, 2018 11:02 am ET
Invictus CEO Update: Building a vertically integrated, horizontally diverse cannabis company
VANCOUVER, Sept. 5, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to reflect on significant milestones that will drive future success with the upcoming legalization of adult recreational cannabis on October 17, 2018. We've signed landmark supply agreements with Alberta and British Columbia, with others to follow suit. We're scaling-up our facilities to meet demand with approximately 200,000 square feet of cultivation capacity expected by the first quarter of 2019. We've diversifying our product portfolio by adding 69
Sep 05, 2018 11:02 am ET
Invictus CEO Update: Building a vertically integrated, horizontally diverse cannabis company
VANCOUVER, Sept. 5, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to reflect on significant milestones that will drive future success with the upcoming legalization of adult recreational cannabis on October 17, 2018. We've signed landmark supply agreements with Alberta and British Columbia, with others to follow suit. We're scaling-up our facilities to meet demand with approximately 200,000 square feet of cultivation capacity expected by the first quarter of 2019. We've diversifying our product portfolio by add
Aug 31, 2018 09:15 am ET
Invictus Launching Recreational Brands
Leading Canadian Cannabis Company Announces New Lifestyle-Inspired Brands
Aug 31, 2018 09:15 am ET
Invictus Launching Recreational Brands
Leading Canadian Cannabis Company Announces New Lifestyle-Inspired Brands
Aug 30, 2018 07:48 am ET
Invictus Signs LOI to Provide GTEC With Strategic Investment and Expand National Distibution
VANCOUVER, Aug. 30, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a binding Letter of Intent with GTEC Holdings Ltd. ("GTEC") (TSXV: GTEC) to provide GTEC with a non-revolving unsecured convertible loan (the "Loan Facility") in an amount up to $2,000,000, and an interest rate of prime plus 5%. Subject to regulatory approvals, all or a portion of the principal and accrued interest on the Loan Facility may be convertible into common shares of GTEC, at the option of Invictus, at any t
Aug 30, 2018 07:48 am ET
Invictus Signs LOI to Provide GTEC With Strategic Investment and Expand National Distibution
VANCOUVER, Aug. 30, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a binding Letter of Intent with GTEC Holdings Ltd. ("GTEC") (TSXV: GTEC) to provide GTEC with a non-revolving unsecured convertible loan (the "Loan Facility") in an amount up to $2,000,000, and an interest rate of prime plus 5%. Subject to regulatory approvals, all or a portion of the principal and accrued interest on the Loan Facility may be convertible into common shares of GTEC, at the option of Invictus, a
Aug 29, 2018 08:00 am ET
Acreage Pharms secures supply agreement with Alberta Gaming, Liquor & Cannabis Commission
VANCOUVER, Aug. 29, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that its wholly-owned Alberta subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has signed a Purchase Order ("PO") with Alberta Gaming, Liquor and Cannabis ("AGLC") to supply the province with a selection of premium cannabis products for the upcoming adult recreational market. The agreement includes an initial one-year term, with two one-year renewal options.
Aug 29, 2018 08:00 am ET
Acreage Pharms secures supply agreement with Alberta Gaming, Liquor & Cannabis Commission
VANCOUVER, Aug. 29, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that its wholly-owned Alberta subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has signed a Purchase Order ("PO") with Alberta Gaming, Liquor and Cannabis ("AGLC") to supply the province with a selection of premium cannabis products for the upcoming adult recreational market. The agreement includes an initial one-year term, with two one-year renewal options.
Aug 21, 2018 08:37 am ET
Invictus Announces Spinout of Poda to Access International and U.S. Markets
VANCOUVER, Aug. 21, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) today announced the proposed spinout of its wholly-owned subsidiary, Poda Technologies Ltd. ("Poda"), by way of plan of arrangement (the "Arrangement"), in a bid to create a stand-alone entity to conduct business in the U.S. and internationally, outside of the TSXV.
Aug 21, 2018 08:37 am ET
Invictus Announces Spinout of Poda to Access International and U.S. Markets
VANCOUVER, Aug. 21, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) today announced the proposed spinout of its wholly-owned subsidiary, Poda Technologies Ltd. ("Poda"), by way of plan of arrangement (the "Arrangement"), in a bid to create a stand-alone entity to conduct business in the U.S. and internationally, outside of the TSXV.
Aug 08, 2018 09:47 am ET
IIROC Trading Resumption - GENE
VANCOUVER, Aug. 8, 2018 /CNW/ - Trading resumes in:
Aug 08, 2018 09:30 am ET
Invictus Secures $25.5 Million Debt Financing from ATB Financial to Fund 180,000 sq. ft. Expansion
VANCOUVER, Aug. 8, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that is has signed a commitment letter for a $25.5 million debt financing arrangement with an interest rate at prime plus 2% per annum (the "Financing") with ATB Financial ("ATB") to accelerate the construction of its Phase 3 and Phase 4 cannabis cultivation facilities (the "Expansion Plan") at Acreage Pharms Ltd. ("Acreage Pharms"), located in West-Central Alberta . The Expansion Plan will add a total of 180,000 square feet of production capac
Aug 08, 2018 09:30 am ET
Invictus Secures $25.5 Million Debt Financing from ATB Financial to Fund 180,000 sq. ft. Expansion
VANCOUVER, Aug. 8, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that is has signed a commitment letter for a $25.5 million debt financing arrangement with an interest rate at prime plus 2% per annum (the "Financing") with ATB Financial ("ATB") to accelerate the construction of its Phase 3 and Phase 4 cannabis cultivation facilities (the "Expansion Plan") at Acreage Pharms Ltd. ("Acreage Pharms"), located in West-Central Alberta . The Expansion Plan will add a total of 180,000 square feet of productio
Aug 08, 2018 08:55 am ET
IIROC Trading Halt - GENE
VANCOUVER, Aug. 8, 2018 /CNW/ - The following issues have been halted by IIROC:
Aug 07, 2018 09:30 am ET
Invictus' Acreage Pharms Receives Oil Extraction License From Health Canada
VANCOUVER, Aug. 7, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that its wholly owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has received an amended license from Health Canada, under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), to include the production of bottled cannabis oil and cannabis resin, effective August 3, 2018.
Aug 07, 2018 09:30 am ET
Invictus' Acreage Pharms Receives Oil Extraction License From Health Canada
VANCOUVER, Aug. 7, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that its wholly owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), has received an amended license from Health Canada, under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"), to include the production of bottled cannabis oil and cannabis resin, effective August 3, 2018.
Aug 02, 2018 07:00 am ET
Invictus Extends Investor Awareness Through Investor Relations and Upgrade to OTCQX® Best Market
VANCOUVER, Aug. 2, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has qualified to trade on the OTCQX® Best Market.
Aug 02, 2018 07:00 am ET
Invictus Extends Investor Awareness Through Investor Relations and Upgrade to OTCQX® Best Market
VANCOUVER, Aug. 2, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that it has qualified to trade on the OTCQX® Best Market.
Jul 20, 2018 09:30 am ET
Invictus signs LOI to acquire medical cannabis clinics and Alberta retail license
VANCOUVER, July 20, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a binding letter of intent ("LOI") to acquire 100% (the "Acquisition") of the issued and outstanding shares of a medical clinic and cannabis retail company ("Clinic and Retail Co") that operates medical clinics in, Alberta, and is awaiting final review and approval for a retail cannabis license from the Alberta Gaming and Liquor Commission ("AGLC).
Jul 20, 2018 09:30 am ET
Invictus signs LOI to acquire medical cannabis clinics and Alberta retail license
VANCOUVER, July 20, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a binding letter of intent ("LOI") to acquire 100% (the "Acquisition") of the issued and outstanding shares of a medical clinic and cannabis retail company ("Clinic and Retail Co") that operates medical clinics in, Alberta, and is awaiting final review and approval for a retail cannabis license from the Alberta Gaming and Liquor Commission ("AGLC).
Jul 18, 2018 09:00 am ET
Invictus Announces Definitive Option Agreement with Late-Stage Application under the ACMPR
VANCOUVER, July 18, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that further to its news release dated May 16, 2018, it has successfully entered into a definitive option agreement with a Late-Stage Applicant ("OptionCo") under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") to acquire 100% (the "Option") of the outstanding shares of OptionCo from its current shareholders (the "Vendors").
Jul 18, 2018 09:00 am ET
Invictus Announces Definitive Option Agreement with Late-Stage Application under the ACMPR
VANCOUVER, July 18, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that further to its news release dated May 16, 2018, it has successfully entered into a definitive option agreement with a Late-Stage Applicant ("OptionCo") under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") to acquire 100% (the "Option") of the outstanding shares of OptionCo from its current shareholders (the "Vendors").
Jul 11, 2018 05:19 pm ET
Invictus Secures Supply Agreement with British Columbia Liquor Distribution Branch
VANCOUVER, July 11, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that it has signed a Memorandum of Understanding ("MOU") with the BC Liquor Distribution Branch ("LDB") to supply the province with a selection of premium cannabis products for the upcoming recreational marketplace. Invictus' portfolio includes award-winning strains, supplied by our wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), located in Alberta.
Jul 11, 2018 05:19 pm ET
Invictus Secures Supply Agreement with British Columbia Liquor Distribution Branch
VANCOUVER, July 11, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that it has signed a Memorandum of Understanding ("MOU") with the BC Liquor Distribution Branch ("LDB") to supply the province with a selection of premium cannabis products for the upcoming recreational marketplace. Invictus' portfolio includes award-winning strains, supplied by our wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage Pharms"), located in Alberta.
Jul 11, 2018 09:30 am ET
Invictus Joins Forces with ABG, World-Leading Branding Company, to Launch Lifestyle-Inspired Cannabis Brands
VANCOUVER, July 11, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) today announced that it has entered into a licensing and marketing services agreement with Authentic Brands Group ("ABG"), a global brand owner and marketing company, to develop a collection of lifestyle-inspired cannabis brands that will launch initially in Canada and rollout in key territories around the world.
Jul 11, 2018 09:30 am ET
Invictus Joins Forces with ABG, World-Leading Branding Company, to Launch Lifestyle-Inspired Cannabis Brands
VANCOUVER, July 11, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) today announced that it has entered into a licensing and marketing services agreement with Authentic Brands Group ("ABG"), a global brand owner and marketing company, to develop a collection of lifestyle-inspired cannabis brands that will launch initially in Canada and rollout in key territories around the world.
Jul 09, 2018 09:38 am ET
Invictus Expands Cultivation Footprint, Adds New Strains to Portfolio
VANCOUVER, July 9, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) announced today the purchase of an additional acre of neighboring land adjacent to AB Laboratories Inc. ("AB Labs") property, dedicated to future expansion opportunities at the facility. The acquisition represents significant progress in AB Labs' growth strategy which involves building a strong production profile in state-of-the-art cultivation spaces.
Jul 09, 2018 09:38 am ET
Invictus Expands Cultivation Footprint, Adds New Strains to Portfolio
VANCOUVER, July 9, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) announced today the purchase of an additional acre of neighboring land adjacent to AB Laboratories Inc. ("AB Labs") property, dedicated to future expansion opportunities at the facility. The acquisition represents significant progress in AB Labs' growth strategy which involves building a strong production profile in state-of-the-art cultivation spaces.
Jul 04, 2018 08:00 am ET
Invictus Receives $5.8 Million from Warrant and Option Exercises and Issues Incentive Stock Options
VANCOUVER, July 4, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that for the current fiscal year, which commenced on February 1, 2018, the Company has received $5,777,267 from the exercise of previously issued warrants and options. A total of 4,346,731 warrants and 337,500 options were exercised for proceeds of $5,267,467 and $509,800, respectively. As a result of such exercises, the Company currently has a total of 96,623,857 common shares issued and outstanding.
Jul 04, 2018 08:00 am ET
Invictus Receives $5.8 Million from Warrant and Option Exercises and Issues Incentive Stock Options
VANCOUVER, July 4, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that for the current fiscal year, which commenced on February 1, 2018, the Company has received $5,777,267 from the exercise of previously issued warrants and options. A total of 4,346,731 warrants and 337,500 options were exercised for proceeds of $5,267,467 and $509,800, respectively. As a result of such exercises, the Company currently has a total of 96,623,857 common shares issued and outstanding.
Jun 29, 2018 08:00 am ET
Horizons ETFs Completes Rebalances of its Marijuana-focused ETFs
TORONTO, June 29, 2018 /CNW/ - Horizons ETFs Management (Canada) Inc. ("Horizons ETFs") has completed the quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF ("HMMJ:TSX") and the Horizons Emerging Marijuana Growers Index ETF ("HMJR:NEO").
Jun 19, 2018 06:00 am ET
Invictus Signs LOI For Cannabis Sales into Germany
VANCOUVER, June 19, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce it has signed a non-binding Letter of Intent ("LOI"), executed on June 13, 2018, to sell dried cannabis to a German importer and distributor of medical cannabis (the "Importer"). The Company will initially commit to selling 1,000 kgs of dried cannabis flower per annum at a price of $6.50 per gram. The volumes and respective prices of dried cannabis flower for the second and consecutive years will be defined in a Definitive Offtake Agreement (t
Jun 19, 2018 06:00 am ET
Invictus Signs LOI For Cannabis Sales into Germany
VANCOUVER, June 19, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce it has signed a non-binding Letter of Intent ("LOI"), executed on June 13, 2018, to sell dried cannabis to a German importer and distributor of medical cannabis (the "Importer"). The Company will initially commit to selling 1,000 kgs of dried cannabis flower per annum at a price of $6.50 per gram. The volumes and respective prices of dried cannabis flower for the second and consecutive years will be defined in a Definitive Offtake Agree
Jun 14, 2018 02:19 pm ET
Jessica Martin Joins Invictus as Vice President, Public Relations and Regulatory Affairs
VANCOUVER, June 14, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) announced today that communications and government relations expert Jessica Martin will join Invictus as Vice President, Public Relations and Regulatory Affairs, effective July 2, 2018.
Jun 14, 2018 02:19 pm ET
Jessica Martin Joins Invictus as Vice President, Public Relations and Regulatory Affairs
VANCOUVER, June 14, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) announced today that communications and government relations expert Jessica Martin will join Invictus as Vice President, Public Relations and Regulatory Affairs, effective July 2, 2018.
Jun 06, 2018 09:10 am ET
Construction at Invictus' AB Labs is Progressing on Schedule
VANCOUVER, June 6, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) announced today that construction of the Phase 2 expansion at AB Laboratories Inc. ("AB Labs") remains on-schedule. The retrofit is well underway with construction of the second-floor mezzanine to commence as early as next week. The Phase 2 facility, located adjacent to Phase 1, will add 40,000 square feet to the current operations and increase total cultivation space to 56,000 square feet. The 16,000 square foot Phase 1 facility continues to operate at full capacity
Jun 06, 2018 09:10 am ET
Construction at Invictus' AB Labs is Progressing on Schedule
VANCOUVER, June 6, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) announced today that construction of the Phase 2 expansion at AB Laboratories Inc. ("AB Labs") remains on-schedule. The retrofit is well underway with construction of the second-floor mezzanine to commence as early as next week. The Phase 2 facility, located adjacent to Phase 1, will add 40,000 square feet to the current operations and increase total cultivation space to 56,000 square feet. The 16,000 square foot Phase 1 facility continues to operate at full c
May 23, 2018 09:40 am ET
Invictus Reflects on Major Milestones Including 2 Sales Licenses under ACMPR
VANCOUVER, May 23, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to highlight major milestones as the fast-growing cannabis Company prepares for the coming recreational marketplace with new construction and development projects, fresh products and a dynamic and muscular approach to retail sales.
May 23, 2018 09:40 am ET
Invictus Reflects on Major Milestones Including 2 Sales Licenses under ACMPR
VANCOUVER, May 23, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to highlight major milestones as the fast-growing cannabis Company prepares for the coming recreational marketplace with new construction and development projects, fresh products and a dynamic and muscular approach to retail sales.
May 18, 2018 05:25 pm ET
Invictus' Acreage Pharms Awarded Sales License
VANCOUVER, May 18, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that Acreage Pharms Ltd. ("Acreage Pharms") has received its sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR) effective May 18, 2018.
May 18, 2018 05:25 pm ET
Invictus' Acreage Pharms Awarded Sales License
VANCOUVER, May 18, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that Acreage Pharms Ltd. ("Acreage Pharms") has received its sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR) effective May 18, 2018.
May 16, 2018 09:25 am ET
Invictus Signs Binding LOI for Option to Acquire BC Licensed Producer Applicant with Two Locations and 32 Acres of Buildable Land
VANCOUVER, May 16, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a binding letter of intent ("LOI") for an option to acquire 100% (the "Option") of the outstanding shares of an applicant (the "OptionCo") under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") from OptionCo current shareholders (the "Vendors").
May 16, 2018 09:25 am ET
Invictus Signs Binding LOI for Option to Acquire BC Licensed Producer Applicant with Two Locations and 32 Acres of Buildable Land
VANCOUVER, May 16, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that it has entered into a binding letter of intent ("LOI") for an option to acquire 100% (the "Option") of the outstanding shares of an applicant (the "OptionCo") under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") from OptionCo current shareholders (the "Vendors").
May 15, 2018 09:30 am ET
Invictus Update on PODA - World's First Truly Zero-Cleaning Vaporizer
VANCOUVER, May 15, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce the summer 2018 launch of Poda - the world's first zero-cleaning vaporizer system. Poda is an innovative technology that can be used to vaporize almost any vaporizable substance, including cannabis, tobacco, e-liquids, concentrates, coffee and more. The revolutionary technology stands apart from previous generations of vaporizers, most of which require cleaning and can only be used effectively for one type of substance.
May 15, 2018 09:30 am ET
Invictus Update on PODA - World's First Truly Zero-Cleaning Vaporizer
VANCOUVER, May 15, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce the summer 2018 launch of Poda - the world's first zero-cleaning vaporizer system. Poda is an innovative technology that can be used to vaporize almost any vaporizable substance, including cannabis, tobacco, e-liquids, concentrates, coffee and more. The revolutionary technology stands apart from previous generations of vaporizers, most of which require cleaning and can only be used effectively for one type of substance.
May 14, 2018 07:00 am ET
Invictus Pursues Aggressive Retail Strategy, Including Dispensary Ownership and Sales in Multiple Provinces and Territories
VANCOUVER, May 14, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce the company's multi-pronged retail strategy, an approach to distributing and selling cannabis that involves the ownership of dispensaries and partnerships with leading retail outlets nationwide. Invictus' multifaceted sales strategy aimed to target each channel for sales and distribution fits squarely within the company's seed-to-sale, vertically integrated business model, which consist of establishing supply agreements and product calls with p
May 14, 2018 07:00 am ET
Invictus Pursues Aggressive Retail Strategy, Including Dispensary Ownership and Sales in Multiple Provinces and Territories
VANCOUVER, May 14, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce the company's multi-pronged retail strategy, an approach to distributing and selling cannabis that involves the ownership of dispensaries and partnerships with leading retail outlets nationwide. Invictus' multifaceted sales strategy aimed to target each channel for sales and distribution fits squarely within the company's seed-to-sale, vertically integrated business model, which consist of establishing supply agreements and product calls
May 11, 2018 08:55 am ET
Cannabis Strain from Invictus' AB Laboratories Now For Sale on Canopy Growth Corporation's Tweed Sales Platform
VANCOUVER, May 11, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that cannabis from the company's AB Laboratories Inc. (AB Labs) is now available for purchase through Canopy Growth Corporation's (TSX: WEED) Tweed Main Street online store and to-date AB Labs has transferred 172 KG of product to Canopy.
May 11, 2018 08:55 am ET
Cannabis Strain from Invictus' AB Laboratories Now For Sale on Canopy Growth Corporation's Tweed Sales Platform
VANCOUVER, May 11, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that cannabis from the company's AB Laboratories Inc. (AB Labs) is now available for purchase through Canopy Growth Corporation's (TSX: WEED) Tweed Main Street online store and to-date AB Labs has transferred 172 KG of product to Canopy.
May 11, 2018 07:00 am ET
Say Hi to AB Labs: the newest CraftGrow partner in the Tweed Main Street store
SMITHS FALLS, ON and ANCASTER, ON, May 11, 2018 /CNW/ - Canopy Growth Corporation (TSX: WEED) ("Canopy Growth" or the "Company") is pleased to announce the addition of high quality cannabis from CraftGrow partner AB Laboratories Inc. ("AB Labs"), part of Invictus MD Strategies Corp ("Invictus") (TSXV: GENE; OTC: IVITF), in the Tweed Main Street online store.
May 08, 2018 11:20 am ET
Invictus' Acreage Pharms' Phase 2 is Now Complete
VANCOUVER, May 8, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that the Acreage Pharms Ltd ("Acreage Pharms") 33,000 square foot, purpose built Phase 2 production facility is complete. Land clearing and site preparation for its 80,000 square foot Phase 3 expansion project has commenced giving the licensed producer a total of 120,000 square feet of growing space by the end of 2018. Acreage Pharms is also working on plans to increase total capacity to 360,000 square feet in 2019. Invictus is fully funded for
May 08, 2018 11:20 am ET
Invictus' Acreage Pharms' Phase 2 is Now Complete
VANCOUVER, May 8, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that the Acreage Pharms Ltd ("Acreage Pharms") 33,000 square foot, purpose built Phase 2 production facility is complete. Land clearing and site preparation for its 80,000 square foot Phase 3 expansion project has commenced giving the licensed producer a total of 120,000 square feet of growing space by the end of 2018. Acreage Pharms is also working on plans to increase total capacity to 360,000 square feet in 2019. Invictus is fully fun
Apr 10, 2018 06:00 am ET
Invictus' Acreage Pharms Acquires 23 New Strains, Expanding Its Genetics Profile
VANCOUVER, April 10, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that Acreage Pharms Ltd ("Acreage Pharms") has received 23 new strains, providing the Company with a broad cannabis cultivation profile including: strains that are high in CBD; strains that offer especially elevated concentrations of THC; and strains that capture a wide variety of terpenes and cannabinoids, increasingly sought after by cannabis consumers.
Apr 10, 2018 06:00 am ET
Invictus' Acreage Pharms Acquires 23 New Strains, Expanding Its Genetics Profile
VANCOUVER, April 10, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that Acreage Pharms Ltd ("Acreage Pharms") has received 23 new strains, providing the Company with a broad cannabis cultivation profile including: strains that are high in CBD; strains that offer especially elevated concentrations of THC; and strains that capture a wide variety of terpenes and cannabinoids, increasingly sought after by cannabis consumers.
Apr 04, 2018 11:30 am ET
Invictus Jumps to Top Five in Share Appreciation Among Canada's Leading Cannabis Companies for 2018 Q1
VANCOUVER, April 4, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce, on the heels of kicking off construction on 40,000 sq. ft. of additional cultivation space and appointing Rock & Roll Hall of Famer Gene Simmons of KISS as Chief Evangelist Officer, Invictus ranked fifth overall in share appreciation among Canada's Cannabis leaders for the first quarter of 2018 and was the overall top performer last week, according to Mackie Research's The Daily Extract - Weekend Edition - April 1, 2018 (source: Capitol
Apr 04, 2018 11:30 am ET
Invictus Jumps to Top Five in Share Appreciation Among Canada's Leading Cannabis Companies for 2018 Q1
VANCOUVER, April 4, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce, on the heels of kicking off construction on 40,000 sq. ft. of additional cultivation space and appointing Rock & Roll Hall of Famer Gene Simmons of KISS as Chief Evangelist Officer, Invictus ranked fifth overall in share appreciation among Canada's Cannabis leaders for the first quarter of 2018 and was the overall top performer last week, according to Mackie Research's The Daily Extract - Weekend Edition - April 1, 2018 (source: C
Apr 02, 2018 12:02 pm ET
Mar 27, 2018 09:10 am ET
Invictus' Chief Evangelist Officer Gene Simmons Tours AB Laboratories
Company Announces Commencement of 40,000 sq. ft. Construction Expansion Project
Mar 27, 2018 09:10 am ET
Invictus' Chief Evangelist Officer Gene Simmons Tours AB Laboratories
Company Announces Commencement of 40,000 sq. ft. Construction Expansion Project
Mar 26, 2018 09:15 am ET
Key On-Site Sales Inspection Completed for Acreage Pharms
VANCOUVER, March 26, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that Acreage Pharms has undergone its physical on site sales license inspection. Health Canada officials are now completing their report. Given Acreage Pharms' strong commitment to closely adhering to regulatory guidelines and requirements, the company remains confident it will pass this important regulatory step and gains its sales license.
Mar 26, 2018 09:15 am ET
Key On-Site Sales Inspection Completed for Acreage Pharms
VANCOUVER, March 26, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that Acreage Pharms has undergone its physical on site sales license inspection. Health Canada officials are now completing their report. Given Acreage Pharms' strong commitment to closely adhering to regulatory guidelines and requirements, the company remains confident it will pass this important regulatory step and gains its sales license.
Mar 20, 2018 11:31 am ET
Invictus Opens TSX Venture Exchange Trading as GENE for the First Time
Company's Chief Evangelist Officer, Rock Legend Gene Simmons On Hand as Trading Opened
Mar 20, 2018 11:31 am ET
Invictus Opens TSX Venture Exchange Trading as GENE for the First Time
Company's Chief Evangelist Officer, Rock Legend Gene Simmons On Hand as Trading Opened
Mar 20, 2018 11:13 am ET
Invictus MD Strategies Corp. Opens the Market
TORONTO, March 20, 2018 /CNW/ - Dan Kriznic, Chairman, CEO, Founder & Director, alongside Gene Simmons, Co-Founder of KISS, and Chief Evangelist Officer, Invictus MD Strategies Corp. (GENE), joined Ungad Chadda, Senior Vice President, Head of Enterprise Corporate Strategy and External Affairs, TMX Group, to open the market. Based out of Vancouver, British Columbia, Invictus is a cannabis company with a portfolio of licensed producers in Alberta and Ontario under the Access to Cannabis for Medical Purposes Regulations (ACMPR). Invictus maintains a land package of over 250 acres of buildab
Mar 19, 2018 02:25 pm ET
Invictus Changes Canadian Ticker to GENE
VANCOUVER, March 19, 2018 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce that the Company is changing its ticker on the TSX Venture Exchange from IMH to GENE effective on March 20, 2018.
Mar 19, 2018 02:25 pm ET
Invictus Changes Canadian Ticker to GENE
VANCOUVER, March 19, 2018 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: IMH; OTC: IVITF; FRA: 8IS1) is pleased to announce that the Company is changing its ticker on the TSX Venture Exchange from IMH to GENE effective on March 20, 2018.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
